Literature DB >> 11153604

Lung cancer in young females.

T Lienert1, M Serke, N Schönfeld, R Loddenkemper.   

Abstract

Previous studies suggested that the characteristics of young female lung cancer patients may differ from those of other patients. Using the cancer registry at the Lungenklinik Heckeshorn hospital, all female patients under the age of 46 yrs with primary lung cancer 1986-1995 were identified. The clinical records were reviewed for risk factors, stage, histology, therapy, and survival. The data were compared with those of other patients. Of the 4,939 patients 96 (1.9%) were females aged <46 yrs. The percentage of young females doubled within ten years from 1 to 2% of all patients (p=0.03). The main risk factor in young females was smoking. Adenocarcinoma and carcinoids were overrepresented, whereas squamous cell and small cell carcinoma were significantly rarer in the young female group. Young females and young males were more likely to have advanced disease and underwent surgery and/or combined treatment significantly more often than older patients. The overall survival was only moderately better in younger patients. The clinical features of young female patients differed from those of young males and older females, the prognosis likewise depended on tumour stage and therapy.

Entities:  

Mesh:

Year:  2000        PMID: 11153604     DOI: 10.1183/09031936.00.16598600

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  9 in total

1.  Smoking reduces survival in young females with lung adenocarcinoma after curative resection.

Authors:  Ming Liu; Gening Jiang; Jiaan Ding; Jiang Fan; Wenxin He; Peng Zhang; Nan Song
Journal:  Med Oncol       Date:  2011-01-30       Impact factor: 3.064

2.  Lung Cancer in the Young.

Authors:  Marco Galvez-Nino; Rossana Ruiz; Joseph A Pinto; Katia Roque; Raul Mantilla; Luis E Raez; Luis Mas
Journal:  Lung       Date:  2019-11-26       Impact factor: 2.584

3.  Effect of smoking on survival from non-small cell lung cancer: a retrospective Veterans' Affairs Central Cancer Registry (VACCR) cohort analysis.

Authors:  Vijaya Raj Bhatt; Rishi Batra; Peter T Silberstein; Fausto R Loberiza; Apar Kishor Ganti
Journal:  Med Oncol       Date:  2014-11-28       Impact factor: 3.064

Review 4.  Estrogen receptor pathways in lung cancer.

Authors:  Laura P Stabile; Jill M Siegfried
Journal:  Curr Oncol Rep       Date:  2004-07       Impact factor: 5.075

5.  Trends and Characteristics of Young Non-Small Cell Lung Cancer Patients in the United States.

Authors:  Anish Thomas; Yuanbin Chen; Tinghui Yu; Marko Jakopovic; Giuseppe Giaccone
Journal:  Front Oncol       Date:  2015-05-26       Impact factor: 6.244

6.  [Survival and prognostic factors of non-small-cell lung cancer among young people in central Tunisia].

Authors:  Samah Joobeur; Ahmed Ben Saad; Asma Migaou; Nesrine Fahem; Saousen Cheikh Mhamed; Naceur Rouatbi
Journal:  Pan Afr Med J       Date:  2020-01-23

7.  A six-month study of pulmonary cancer in Albanian women.

Authors:  Jolanda Nikolla; Milda Nanushi; Gentian Vyshka; Hasan Hafizi
Journal:  ISRN Prev Med       Date:  2013-03-04

8.  Young age increases risk for lymph node positivity but decreases risk for non-small cell lung cancer death.

Authors:  Wenjie Xia; Anpeng Wang; Meng Jin; Qixing Mao; Wenying Xia; Gaochao Dong; Bing Chen; Weidong Ma; Lin Xu; Feng Jiang
Journal:  Cancer Manag Res       Date:  2018-01-08       Impact factor: 3.989

9.  Altered expression of 17‑β‑hydroxysteroid dehydrogenase type 2 and its prognostic significance in non‑small cell lung cancer.

Authors:  Hanna Drzewiecka; Donata Jarmołowska-Jurczyszyn; Andrzej Kluk; Bartłomiej Gałęcki; Wojciech Dyszkiewicz; Paweł P Jagodziński
Journal:  Int J Oncol       Date:  2020-03-19       Impact factor: 5.650

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.